Home » Lawmaker Seeks U.S. FDA’s Input on Making Firms Accountable for Outsourcing
Lawmaker Seeks U.S. FDA’s Input on Making Firms Accountable for Outsourcing
July 15, 2008
As Congress continues its inquiries into the U.S. Food and Drug Administration’s (FDA) regulation of imported drugs and ingredients, a senator is asking Center for Drug Evaluation and Research Director Janet Woodcock for the best ways to hold pharmaceutical companies responsible for contaminated drugs when they outsource production of ingredients to other countries.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor